Home LiteratureArticle Details
PMID: 8013468 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.

The EMBO journal ·Vol. 13 ·No. 11 ·1994-06-01 ·Pages 2699-707

Bijlmakers MJ, Benaroch P, Ploegh HL

Abstract

MHC class II molecules usually bind peptides in the endocytic pathway, but can also present endogenous peptides from newly synthesized proteins in a chloroquine-insensitive manner, suggesting that peptide binding might occur in the endoplasmic reticulum (ER). We used in vitro translation of HLA-DR1 class II molecules in the presence of microsomes to study peptide binding in the ER. Formation of functional class II molecules in vitro depends on formation of disulfide bridges in alpha and beta chains. The class II alpha beta heterodimers made by in vitro translation resemble class II molecules synthesized in cells in (i) their reactivity with conformation-specific antibodies, (ii) their assembly with Ii chain homotrimers, (iii) the generation of SDS-stable dimers upon peptide binding and (iv) their specificity of peptide binding. The assembly of class II molecules occurs via an alpha beta intermediate and can occur post-translationally, but only in intact microsomes. Class II alpha beta heterodimers are able to bind peptides in ER-derived microsomes, a process that precludes subsequent association of class II molecules with Ii chain. This mechanism might explain presentation of endogenous peptides by class II molecules.

MeSH Terms
Antibodies, Monoclonal Antigens, Differentiation, B-Lymphocyte Antigens, Neoplasm/genetics,metabolism Cross-Linking Reagents Dithiothreitol Endoplasmic Reticulum/metabolism Glutathione/analogs & derivatives Glutathione Disulfide HLA-DR1 Antigen/analysis,chemistry,genetics,metabolism Hemagglutinin Glycoproteins, Influenza Virus Hemagglutinins, Viral/metabolism Histocompatibility Antigens Class II/genetics,metabolism Microsomes/metabolism Peptide Fragments/metabolism Protein Binding Protein Biosynthesis Protein Conformation Protein Structure, Secondary RNA, Messenger/biosynthesis Succinimides Viral Envelope Proteins/metabolism
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, B-Lymphocyte Antigens, Neoplasm Cross-Linking Reagents HLA-DR1 Antigen Hemagglutinin Glycoproteins, Influenza Virus Hemagglutinins, Viral Histocompatibility Antigens Class II Peptide Fragments RNA, Messenger Succinimides Viral Envelope Proteins invariant chain dithiobis(succinimidylpropionate) Glutathione Dithiothreitol Glutathione Disulfide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bijlmakers M J
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.
Benaroch P
Ploegh H L
References (76)
76 references, click to expand
  1. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain.
    EMBO J. 1986 Dec 20;5(13):3483-8 PMID: 3104027
  2. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
    J Immunol. 1993 Jan 15;150(2):499-507 PMID: 8419482
  3. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective.
    Cell. 1993 Aug 13;74(3):577-84 PMID: 8348620
  4. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.
    Nature. 1991 Dec 5;354(6352):392-4 PMID: 1956401
  5. Two populations of Ia-like molecules on a human B cell line.
    J Immunol. 1980 Jul;125(1):293-9 PMID: 6966655
  6. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.
    Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2282-6 PMID: 1549594
  7. cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure.
    Proc Natl Acad Sci U S A. 1983 Dec;80(24):7395-9 PMID: 6324166
  8. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
    Nature. 1993 Jul 1;364(6432):33-9 PMID: 8316295
  9. A role for peptide in determining MHC class II structure.
    Nature. 1991 Sep 12;353(6340):167-70 PMID: 1653903
  10. Human major histocompatibility complex class II invariant chain is expressed on the cell surface.
    J Biol Chem. 1990 Apr 5;265(10):5787-92 PMID: 1690714
  11. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  12. Sequence analysis of peptides bound to MHC class II molecules.
    Nature. 1991 Oct 17;353(6345):622-7 PMID: 1656276
  13. Isolation and characterization of human B cell alloantigens.
    J Immunol. 1976 Nov;117(5 Pt 1):1589-93 PMID: 826591
  14. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.
    J Virol. 1989 Apr;63(4):1756-62 PMID: 2784508
  15. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.
    Nature. 1988 Apr 28;332(6167):845-50 PMID: 3258651
  16. Isolation and characterization of antigen-Ia complexes involved in T cell recognition.
    Cell. 1986 Dec 26;47(6):1071-7 PMID: 3490919
  17. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
    Hum Immunol. 1985 Apr;12(4):191-211 PMID: 3921497
  18. Cellular studies on antigen presentation by class II MHC molecules.
    Curr Opin Immunol. 1992 Feb;4(1):63-9 PMID: 1596369
  19. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    J Exp Med. 1990 Sep 1;172(3):947-54 PMID: 2388037
  20. Human B cells alloantigens; separation from other membrane molecules by affinity chromatography.
    Eur J Immunol. 1977 Sep;7(9):636-9 PMID: 303569
  21. A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3).
    J Immunol. 1984 Apr;132(4):1900-5 PMID: 6199417
  22. Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.
    J Exp Med. 1990 Mar 1;171(3):875-87 PMID: 1968506
  23. Structural model of HLA-DR1 restricted T cell antigen recognition.
    Cell. 1988 Feb 26;52(4):515-23 PMID: 2963699
  24. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
    J Exp Med. 1990 Sep 1;172(3):779-88 PMID: 2117634
  25. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.
    Cell. 1990 Nov 16;63(4):707-16 PMID: 2121367
  26. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum.
    EMBO J. 1992 May;11(5):1717-22 PMID: 1582407
  27. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.
    J Exp Med. 1992 Jul 1;176(1):119-28 PMID: 1613454
  28. The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.
    Eur J Immunol. 1993 Jun;23(6):1305-13 PMID: 8500526
  29. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.
    Nature. 1992 Jun 25;357(6380):702-4 PMID: 1614517
  30. Early disulfide bond formation prevents heterotypic aggregation of membrane proteins in a cell-free translation system.
    J Cell Biol. 1992 Jul;118(2):245-52 PMID: 1352780
  31. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    J Immunol. 1991 Nov 15;147(10):3306-13 PMID: 1658143
  32. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    J Immunol. 1991 May 1;146(9):2944-51 PMID: 1673146
  33. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.
    Science. 1992 Jun 26;256(5065):1817-20 PMID: 1319610
  34. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens.
    Cell. 1982 May;29(1):61-9 PMID: 6955026
  35. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route.
    Cell. 1990 Apr 6;61(1):171-83 PMID: 2156628
  36. Intracellular transport of class II MHC molecules directed by invariant chain.
    Nature. 1990 Dec 13;348(6302):600-5 PMID: 2250716
  37. Independent and synergistic effects of disulfide bond formation, beta 2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system.
    J Immunol. 1992 Nov 1;149(9):2935-44 PMID: 1401922
  38. Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):8188-92 PMID: 2999796
  39. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5998-6002 PMID: 2068076
  40. Structure of the human class I histocompatibility antigen, HLA-A2.
    Nature. 1987 Oct 8-14;329(6139):506-12 PMID: 3309677
  41. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Nature. 1990 Jul 5;346(6279):63-6 PMID: 2366863
  42. The preparation and properties of gel-filtered rabbit-reticulocyte lysate protein-synthesis systems.
    Eur J Biochem. 1983 Mar 15;131(2):289-301 PMID: 6832153
  43. Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association.
    J Biol Chem. 1977 Sep 10;252(17):6201-7 PMID: 302259
  44. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens.
    J Cell Biol. 1990 Sep;111(3):839-55 PMID: 2391366
  45. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells.
    J Exp Med. 1992 Sep 1;176(3):657-66 PMID: 1512535
  46. Refolding and reassembly of separate alpha and beta chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity.
    Proc Natl Acad Sci U S A. 1990 Jun;87(11):4134-8 PMID: 2349223
  47. Mice lacking the MHC class II-associated invariant chain.
    Cell. 1993 Feb 26;72(4):635-48 PMID: 7679955
  48. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    J Immunol. 1992 Jun 1;148(11):3478-82 PMID: 1588042
  49. New genes in the MHC that encode proteins for antigen processing.
    Trends Cell Biol. 1992 Mar;2(3):81-6 PMID: 14731949
  50. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nature. 1990 Jan 4;343(6253):74-6 PMID: 1967486
  51. Peptide translocation by variants of the transporter associated with antigen processing.
    Science. 1993 Dec 24;262(5142):2059-63 PMID: 8266106
  52. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
    J Immunol. 1982 Dec;129(6):2564-9 PMID: 6982931
  53. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
    Nature. 1990 Jun 14;345(6276):615-8 PMID: 2190094
  54. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.
    Nature. 1993 Jun 24;363(6431):725-8 PMID: 8515815
  55. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Nature. 1992 Aug 27;358(6389):764-8 PMID: 1380674
  56. Gel electrophoresis in studies of protein conformation and folding.
    Anal Biochem. 1984 Apr;138(1):1-18 PMID: 6203436
  57. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3150-4 PMID: 2014234
  58. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells.
    Proc Natl Acad Sci U S A. 1989 Jan;86(1):282-6 PMID: 2492101
  59. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter.
    Science. 1993 Aug 6;261(5122):769-71 PMID: 8342042
  60. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells.
    Eur J Immunol. 1989 Oct;19(10):1903-9 PMID: 2479567
  61. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain.
    EMBO J. 1994 Feb 15;13(4):934-44 PMID: 8112308
  62. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments.
    Nature. 1991 Feb 21;349(6311):669-76 PMID: 1847504
  63. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.
    J Exp Med. 1986 Nov 1;164(5):1490-504 PMID: 2430042
  64. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
    Nature. 1992 Dec 3;360(6403):474-7 PMID: 1448172
  65. Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins.
    Cell. 1982 Aug;30(1):153-61 PMID: 6812963
  66. Antigen processing for presentation by MHC class I molecules.
    Curr Opin Immunol. 1992 Feb;4(1):59-62 PMID: 1596368
  67. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
    J Immunol. 1990 Mar 1;144(5):1849-56 PMID: 2307844
  68. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain.
    J Exp Med. 1986 Nov 1;164(5):1478-89 PMID: 3464691
  69. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.
    J Exp Med. 1993 Jun 1;177(6):1699-712 PMID: 8098731
  70. Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum.
    Nature. 1992 Mar 19;356(6366):260-2 PMID: 1552946
  71. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2346-50 PMID: 1900941
  72. DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype.
    Proc Natl Acad Sci U S A. 1985 May;82(10):3405-9 PMID: 3858829
  73. Cell-free synthesis and processing of the heavy and light chains of HLA-DR antigens.
    J Exp Med. 1980 Aug 1;152(2 Pt 2):65s-82s PMID: 6967942
  74. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen.
    J Exp Med. 1988 Jul 1;168(1):293-306 PMID: 2456369
  75. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3290-4 PMID: 1707537
  76. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Nature. 1990 Nov 1;348(6296):39-44 PMID: 2234057
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1994-06-01
Pages
2699-707
Language
English
Region
England
NLM ID
8208664
PMCID
PMC395144
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]